Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Rheostat Therapeutics
c/o LabCentral
700 Main Street, North
Cambridge, MA 02139
Phone: 617-863-3650

Rheostat is working to develop novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy. Its central thesis is that the degradation of toxic cellular components is a fundamental node of biology. The mutations that impair these clearance pathways have been linked with multiple neurodegenerative diseases, many of which are associated with cognitive impairment like Parkinson's disease. The company is working to leverage its understanding of these pathways to discover and develop novel small molecules that will restore cellular balance and treat neurodegenerative and rare diseases.

Key Contact
NameTitleE-Mail
Josh ResnickChairman


Funding Events
DateAmountTypeInvestors
11/26/18$23,000,000Series A AbbVie Biotech Ventures
Alexandria Real Estate Equities
Amgen Ventures
Dementia Discovery Fund
Mayo Clinic
MRL Ventures Fund  
SV Health Investors
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.